CSL Ltd (ASX: CSL) shares have been sold off recently and are down near multi-year lows. Is now the time to buy?

Morgan Stanley initiated coverage of CSL (CSLLY) with an Overweight rating and A$313 price target A “solid revenue growth outlook” and margin ...

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either BioMarin Pharmaceutical (BMRN) or CSL Limited Sponsored ADR (CSLLY). But which of these two ...

Brokers gave buy ratings to these ASX shares last week. Why are they bullish? The post Top brokers name 3 ASX shares to buy ...

Oscar's Disappointment in the Chinese Super League ...

It’s a tough job analysing share prices and company performances in the middle of a sharp share market downturn, but ...

Analysts think these quality shares could be top picks for your hard-earned money. The post How to invest $10,000 like Warren ...

A partnership that sprouted from the soybean commodity in Michigan has blossomed into an alliance that has the potential to boost trade on the St. Lawrence Seaway. The Great Lakes Sustainable Shipping ...

India, Italy discuss the scope to expand military focused cooperation during recently held Military Cooperation Group in Rome ...

We recently published a list of 10 Worst High-Risk High-Reward Growth Stocks To Buy. In this article, we are going to take a ...

Tom Lee managing partner and head of research at Fundstrat Global Advisors appeared on a CNBC interview to talk about how the ...